Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
ATEC 
Alphatec Holdings Inc (ATEC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/28/2025: ATEC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $18.95
1 Year Target Price $18.95
| 4 | Strong Buy |
| 5 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 12.98% | Avg. Invested days 33 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  2.0 | Stock Returns Performance  2.0 |
| Profits based on simulation | Last Close 08/28/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.35B USD | Price to earnings Ratio - | 1Y Target Price 18.95 |
Price to earnings Ratio - | 1Y Target Price 18.95 | ||
Volume (30-day avg) 10 | Beta 1.05 | 52 Weeks Range 4.88 - 16.46 | Updated Date 08/29/2025 |
52 Weeks Range 4.88 - 16.46 | Updated Date 08/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -24.33% | Operating Margin (TTM) -6.19% |
Management Effectiveness
Return on Assets (TTM) -7.61% | Return on Equity (TTM) -376.89% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 2801745913 | Price to Sales(TTM) 3.45 |
Enterprise Value 2801745913 | Price to Sales(TTM) 3.45 | ||
Enterprise Value to Revenue 4.11 | Enterprise Value to EBITDA -18.89 | Shares Outstanding 147984000 | Shares Floating 116014840 |
Shares Outstanding 147984000 | Shares Floating 116014840 | ||
Percent Insiders 21.03 | Percent Institutions 69.12 |
Upturn AI SWOT
Alphatec Holdings Inc
Company Overview
History and Background
Alphatec Holdings Inc. was founded in 2006. It has evolved from a small medical device company to a significant player in the spine technology market, focusing on innovation and comprehensive spine solutions.
Core Business Areas
- Spinal Implants: Develops and markets a range of spinal implants for various spinal conditions, including degenerative disc disease, spinal stenosis, scoliosis, and trauma.
- Biologics: Offers a portfolio of biologic solutions to promote spinal fusion and healing.
- Surgical Access Systems: Provides surgical access systems and instruments for minimally invasive spine surgery.
- Navigation: Offers advanced navigation and imaging solutions to improve the accuracy and efficiency of spine surgery.
Leadership and Structure
The leadership team includes Pat Miles (Chairman & CEO). The company is structured with functional departments overseeing R&D, sales, marketing, operations, and finance.
Top Products and Market Share
Key Offerings
- Safe-Guard: A portfolio of spine implants and instrumentation systems designed for thoracolumbar fixation. Competitors include Medtronic, Stryker, and DePuy Synthes. Market share data is proprietary, but Alphatec is a growing player.
- EOS Imaging: Full body, low dose 2D/3D imaging, helps surgeons understand the spine patient pre-op and post-op. Competitors include Siemens, GE and Philips. Market share data is proprietary, but Alphatec is a growing player.
- Invictus: A spinal fixation system, known for its versatility and ease of use. Competitors include Medtronic, Stryker, and DePuy Synthes. Market share data is proprietary, but Alphatec is a growing player.
- ATEC Spine: A suite of spinal implants, instruments, and biologics. Competitors include Medtronic, Stryker, and DePuy Synthes. Market share data is proprietary, but Alphatec is a growing player.
Market Dynamics
Industry Overview
The spine market is a large and competitive market driven by an aging population, technological advancements, and increasing demand for minimally invasive procedures. The market is experiencing continued growth and is driven by both technological advances and new procedures.
Positioning
Alphatec Holdings is positioned as an innovator in the spine technology market, focusing on developing and marketing comprehensive solutions and advanced surgical techniques.
Total Addressable Market (TAM)
The global spine surgery market is estimated to be around $10 billion. Alphatec Holdings is aiming to increase its market share through product innovation and strategic acquisitions.
Upturn SWOT Analysis
Strengths
- Innovative product portfolio
- Focus on surgeon education and training
- Strategic acquisitions to expand product offerings
- Strong relationships with key opinion leaders
- Growing market share in the spine market
Weaknesses
- Limited brand recognition compared to larger competitors
- Lower profitability relative to competitors
- High dependence on key opinion leaders
- Smaller sales and marketing infrastructure
- History of losses
Opportunities
- Expanding market share in the growing spine market
- Developing new and innovative products
- Expanding into new geographic markets
- Acquiring complementary businesses
- Partnerships to leverage technologies
Threats
- Intense competition from larger companies
- Price pressure from healthcare providers
- Regulatory changes
- Product liability lawsuits
- Economic downturns
Competitors and Market Share
Key Competitors
- MDT
- JNJ
- STRY
Competitive Landscape
Alphatec competes with larger, more established companies in the spine market. It is building its market share through product innovation, strategic acquisitions, and a focus on surgeon education.
Major Acquisitions
EOS imaging
- Year: 2020
- Acquisition Price (USD millions): 117
- Strategic Rationale: Acquisition of EOS imaging to integrate advanced imaging technology into Alphatec's product offerings and enhance surgical planning capabilities.
Growth Trajectory and Initiatives
Historical Growth: Alphatec Holdings has experienced strong revenue growth in recent years, driven by new product launches and strategic acquisitions.
Future Projections: Analysts expect revenue growth to continue in the coming years. Continued improvements in profitability are expected with scale.
Recent Initiatives: Recent initiatives include new product launches, expansion of distribution channels, and acquisitions of complementary businesses.
Summary
Alphatec Holdings is a growing player in the spine technology market, driven by product innovation and strategic acquisitions. While it faces strong competition, its comprehensive solutions and surgeon-focused approach position it for continued growth. It needs to look out for intense competition and integration risks associated with acquisitions and maintain focus on efficiency and profitability as it scales.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company filings (10-K, 10-Q), Investor presentations, Press releases, Analyst reports
- Industry reports, Market research reports
Disclaimers:
This analysis is for informational purposes only and does not constitute financial advice. Market data and analyst estimates are subject to change. Consult a financial professional before making any investment decisions.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Alphatec Holdings Inc
Exchange NASDAQ | Headquaters Carlsbad, CA, United States | ||
IPO Launch date 2006-06-02 | Executive Chairman, CEO & President Mr. Patrick S. Miles | ||
Sector Healthcare | Industry Medical Devices | Full time employees 867 | Website https://www.atecspine.com |
Full time employees 867 | Website https://www.atecspine.com | ||
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants and instruments. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissues; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. Alphatec Holdings, Inc. was founded in 1990 and is headquartered in Carlsbad, California.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.